# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-259805
Filing Date
2024-11-15
Accepted
2024-11-15 16:02:17
Documents
145
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 20-F | d872361d20f.htm iXBRL | 20-F | 3128188
2 | EX-2.2 | d872361dex22.htm | EX-2.2 | 50116
3 | EX-4.21 | d872361dex421.htm | EX-4.21 | 60328
4 | EX-11.1 | d872361dex111.htm | EX-11.1 | 98331
5 | EX-12.1 | d872361dex121.htm | EX-12.1 | 10446
6 | EX-12.2 | d872361dex122.htm | EX-12.2 | 10397
7 | EX-13.1 | d872361dex131.htm | EX-13.1 | 5989
8 | EX-15.1 | d872361dex151.htm | EX-15.1 | 1927
9 | EX-15.2 | d872361dex152.htm | EX-15.2 | 2193
10 | EX-97.1 | d872361dex971.htm | EX-97.1 | 28746
16 | GRAPHIC | g872361g1029115046252.jpg | GRAPHIC | 3561
17 | GRAPHIC | g872361g1106090420108.jpg | GRAPHIC | 38336
| Complete submission text file | 0001193125-24-259805.txt |  | 15382783

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | kzia-20240630.xsd | EX-101.SCH | 150364
12 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | kzia-20240630_cal.xml | EX-101.CAL | 59907
13 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | kzia-20240630_def.xml | EX-101.DEF | 459203
14 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | kzia-20240630_lab.xml | EX-101.LAB | 738648
15 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | kzia-20240630_pre.xml | EX-101.PRE | 633050
148 | EXTRACTED XBRL INSTANCE DOCUMENT | d872361d20f_htm.xml | XML | 3181441

Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 241467722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)